FDA Commissioner Marty Makary said the agency has sent more warning letters to pharma and telehealth companies in the last six months than in the entire decade before that
For weight management specifically, the FDA has approved semaglutide 2.4 mg weekly (Wegovy), liraglutide 3.0 mg daily (Saxenda), and tirzepatide (Zepbound) for adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
It definitely gives me the energy I need
A common expectation is around 12 lbs per week weight loss , although this depends on factors like diet, dosage, and consistency
Additionally, some older weight loss medications with banned substances did carry thrombotic risks, creating lasting skepticism toward newer therapies
Like Semaglutide, this medicine can help patients speed up their metabolism and see a greater loss of fat when exercising and eating right